Avoid social media policies that chill communication, US industry tells FDA
This article was originally published in SRA
Executive Summary
Now that the biopharmaceutical industry has had a chance to review the first real set of guidelines from the Food and Drug Administration on the use of social media1, drug makers wasted no time in telling the agency that the rules directing use of Twitter, Facebook, YouTube and other websites need some tweaking, if not overhauling, in some areas.